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ABSTRACT
Objective: The objective of the study is simple, sensitive; eco-friendly reverse phase chromatographic method has been developed and validated for 
the quantitative determination of ofloxacin in bulk and marketed formulation.
Method: The developed method was done using Hypersil silica C18 (250 mm × 4.6 mm, 5 µ particle size) as column and the mobile phase is containing 
water and methanol in the ratio of (10:90) vol/vol. The mobile phase pass at 1 ml/min flow rate and the eluted solution is measured at 270 nm using 
a PDA detector.
Results: The assay method is linear from the concentration range of 5–30 µg/ml. The corelation coefficient is 0.9998. The mean percentage recovery 
for the developed method is found to be in the range of 98.4–100.6%. The developed method complies robustness studies.
Conclusion: The validation of the developed method was done by as per the ICH guidelines. It obeys the linearity, accuracy, precision, and robustness 
studies. Validation parameters are within the limitations. The results of the developed process indicated the reverse phase chromatographic method 
is simple, accurate as well as precise, rapid and eco-friendly method for routine analysis of ofloxacin in bulk and its pharmaceutical dosage form.
Keywords: Reverse phase high performance liquid chromatography, Validation, Tablets, Ofloxacin.
INTRODUCTION
Ofloxacin [1-3] is a synthetic broad-spectrum antimicrobial agent. Ofloxacin 
is a fluorinated carboxyquinolone; it is the racemate substance. The IUPAC 
name of ofloxacin is (±) 9 fluoro-2, 3, dihydro- 3methyl -10 (4methyl-1-
piperazenyl)-7 oxo-7H pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic 
acid. Ofloxacin is a quinolone derivative, containing the one or more 
fluorine substitutions. The fluoroquinolones the first generation was 
introduced in 1980 have one fluoro substitution. The compounds with 
additional fluoro and other substitutions have been developed in 1990 
- the developed compound extending the antimicrobial activity to Gram-
positive cocci and anaerobes.
The molecular formula is C18H20FN3O4 and molecular weight of the 
compound is 361.368 g/mol, and melting point of the compound is 250–
257°C (482–495°F) (Fig. 1). It is more [3] potent against Gram-positive 
and anaerobes. It inhibits the growth of bacteria by inhibiting bacterial cell 
division. The growth of bacteria cell division inhibited by DNA gyrase enzyme, 
a type II topoisomerase IV enzyme. It is an enzyme necessary to separate 
and replicated DNA the literature survey showed that there are some 
analytical methods reported for ofloxacin such as spectrophotometric [4-6], 
liquid chromatographic [7-10], and high-performance thin-layer 
chromatography [11] individually or in combination with other drugs. The 
reported method is simple, sensitive, accurate, precise, and reliable for the 
determination of ofloxacin in bulk and formulation. The proposed method 




The ofloxacin pure standard drug was collected from Sai Mirra 
Pharmaceuticals Pvt. Ltd., Chennai. The tablet dosage form 
(ofloxacin 200 mg) was procured from local market analytical 
grade chemicals, and HPLC grade solvents are procured from Merck 
Specialties Pvt. Ltd. (Mumbai, India).
Instrumentation
A automatic Shimadzu reversed-phase high-performance liquid 
chromatographic system consists of a LC-20 AD solvent delivery system 
(pump), SPD-M20A photodiode array detector, rheodyne injector with 
20°5L loop volume, and LC- (class VP Software solution) assisted for 
data collections and processing. The analysis was carried out using 
Hypersil silica (C18 250 mm × 4.6 mm, 5 μ). The process was  carried 
out at ambient temperature. The HPLC grade methanol and water in 
the ratio of 10:90 and flow rate of mobile phase at 1.0 ml/min. The 
detection wavelength is 270 nm.
Methodology
Mobile phase
The mobile phase is prepared by mixing chromatographic grade 
methanol and water in the ratio of (90:10) v/v. The mixed solvents are 
sonicated at 3000 rpm and keep it as a mobile phase.
Standard solution
The 50 mg of standard powder drug was weighed and transferred 
into 50 ml standard flask. Dilute the drug with methanol to make the 
concentration of1m. Further dilutions are made using methanol and 
prepare 10 µg/ml solutions.
Sample solution
Weigh accurately 20 tablets and the average weight was calculated. 
The amount of powdered tablet is equivalent to 50 mg and transferred 
to 50 ml volumetric flask, then add HPLC grade methanol and try to 
dissolve as it possible. The solution was filtered through Whatman 
filter paper. The filtrate was further diluted with the methanol to 
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prepare the final concentration of working sample equivalent to 
10 µg/ml solution.
Working procedure
The stabilization of chromatographic system is done by passing mobile 
phase continuously and developed baseline graph. The detector 
wavelength was set at 270 nm by UV spectra and flow rate fixed at 
1.0 mL/min. First to inject the blank solution followed by six replicates 
of the single standard solution then collected the chromatogram. 
The system suitability parameters are verified. The six replicates of 
standard solutions 5, 10, 15, 20, 25, and 30 µg/mL are injected. The 
calibration curve is plotted between the concentration and peak area. 
The linearity curve showed by Fig. 2. The amount of drug substance 
present in sample solution calculated by the direct comparison method.
Method validation
System suitability
The system suitability test for a developed chromatographic procedure 
is relative standard deviation (RSD) <2%, tailing factor <1.5, and 
theoretical plates >1500. The chromatographic parameters are 
evaluated for the developed process.
Linearity
The linearity was studied using five standard solutions covering the 
range of 5–30 µg/ml of ofloxacin. The 1.0 ml, 1.5 ml, 2.0 ml, 2.5 ml, 
and 3.0 ml of aliquots of stock solution are pipetted out into 50 ml 
standard flasks and diluted to the mark with the mobile phase to get the 
concentrations of 5 µg/ml, 10 µg/ml, 15 µg/ml, 20 µg/ml, and 25 µg/ml 
of ofloxacin.
Detection limit (LOD) and quantification limit (LOQ)
From the linearity studies, we determine the LOD and LOQ. The 
standard deviation, intercept, and slope value are used for calculation.
Method precision
The method precision was verified by interday and intraday analysis, 
the measurement of peak areas of repeated solutions 15 µg/ml of 
ofloxacin.
Accuracy
The accuracy of the developed method calculated by recovery studies 
the 50%, 100%, and 150% of the different working strength of ofloxacin 
was used for recovery study.
Robustness
Robustness is the one of the validation parameter. It verified by 
changing small, unique changes in method parameters such as flow 
rate and detection wavelength of the method parameter. We did the 
changes in detection wavelength ±2 nm changes and flow rate was 
varied ±0.2 ml/min.
RESULTS AND DISCUSSION
A simple reversed-phase chromatographic process was reported for 
the estimation of ofloxacin in bulk and marketed formulation. The 
optimization process for chromatographic parameters carried out by 
changing the mobile phase composition.
Mobile phase characteristics
The ideal separation of the drug was done using isocratic condition. 
The HPLC grade water and methanol are supplied in the ratio of 10:90 
(v/v) as the mobile phase. The sharp peak with baseline separation is 
developed by doing a number of experiments and then only we selected 
the mobile phase. The interfering peaks are peaks removed by doing 
number of experiments. It was proved that the selected solvent is 
more suitable for this analytic. The chromatographic peak was defined 
better, resolved, and almost free from tailing effect. Asymmetric peak 
Fig. 1: Molecular structure of ofloxacin
Fig. 2: Optimized chromatogram of ofloxacin sample
Table 1: Optimized chromatographic conditions of ofloxacin 
parameters
Parameters Results





Volume of Injection 20 µl
Mobile phase flow rate 1.0 ml/min
Runtime 10 min




Table 2: Linearity study of ofloxacin
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of ofloxacin obtained using the selected mobile phase with shorter 
analysis time. The mobile phase containing only methanol and water, 
both are eco-friendly solvents, and it does not produce harmful 
effects to the environment. The Chromatographic condition Ofloxacin 
parameters showed in the Table 1.
Linearity
The linearity study verifies that the concentration of selected drug 
ofloxacin obeys the Beer’s and Lambert’s law limit. Where analyte 
response is linearly proportional to concentration. The linearity studies 
carried out by taking in the concentration range of 5–30 µg/mL. The 
result is indicated that the peak areas are linear within the concentration 
of analysis. The correlation coefficient was R² = 1 (Fig. 3). The Linearity 
values of Ofloxacin showed in the Table 2
Accuracy
The standard addition method was used for accuracy studies. The 
pre-analyzed sample solution treated with standard solution. The 
percentage recovery was calculated using peak area. The satisfactory 
recoveries of 98%, 99.33%, 99.06%, 100.06%, and 101.33% are 
Fig. 3: Linearity curve of ofloxacin
Table 3: Recovery studies of ofloxacin








% Recovered S.D % RSD
Ofloxacin 1. 15 15 30.01 14.70 98.00
2. 15 15 30.12 14.90 99.33 1.23 2.00
3. 15 15 28.56 14.86 99.06
4. 15 15 29.92 15.01 100.06
5. 15 15 29.95 15.20 101.33
RSD: Relative standard deviation
Table 4: Intraday analysis of ofloxacin
Drug Sample no. Amount taken* (µg/ml) Amount found (µg/ml) Percentage obtained Average % S.D %RSD
Ofloxacin 1. 15 14.88 99.2
2. 15 14.83 98.87 97.80 0.9582 1.82
3. 15 15.10 100.67
Average value of six replicates, RSD: Relative standard deviation
Table 5: Interday analysis of ofloxacin
Drug Sample no. Concentration taken (µg/ml) Concentration found (µg/ml) Percentage obtained Average % S.D %RSD
1. 15 14.73 98.2
Ofloxacin 2. 15 14.86 99.07 99.00 1.3781 2.00
3. 15 15.14 100.9
RSD: Relative standard deviation
Table 6: Quantification of the formulation
Sample name Sample no. Added amount (µg/ml) Amount present (µg/ml) Percentage obtained Mean value in % S.D RSD in %
1. 15 14.89 99.26
2. 15 14.99 99.87
Ofloxacin 3. 15 14.59 97.26 99.09 1.4189 1.00
4. 15 15.14 100.9
5. 15 14.73 98.2
RSD: Relative standard deviation
101
Asian J Pharm Clin Res, Vol 11, Special Issue 4, 2018, 98-101
 Sumithra et al. 
obtained for the developed method. It indicates that the method was 
complies the accuracy studies. The Recovery studies values of Ofloxacin 
showed in Table 3.
Intraday precision
The intraday precision analysis, we are used for three replicate standard 
solutions (15 µg/ml) of ofloxacin. The recovery of the drug analyzed as 
per the ICH guidelines. The percentage RSD was calculated, and it was 
found that 1.82. It indicates that the proposed method is more précised. 
The intraday analysis of Ofloxacin showed in the Table 4.
Interday precision
The interday precision analysis was done using six replicates of 
ofloxacin standard solutions (15 µg/ml). The percentage RSD was 
calculated, and it was found to be 1.2781. It indicates the developed 
method complies reproducibility. The Interday analysis of Ofloxacin 
showed in the Table 5.
Specificity
The additives present in the formulation are verified, and the specificity 
values for the developed method are within limit. Hence, the developed 
method chromatographic parameters are specific for ofloxacin, 
excipients, and others.
LOD and LOQ
The LOQ estimated by injecting the standard solutions. A signal-to-
noise ratio (S/N) of 3 is a limit to accepted for estimating LOD and S/N 
ratio of 10 is used for estimating LOQ. This method is commonly used to 
exhibit baseline noise. The LOD and LOQ for ofloxacin were found to be 
2.24 µg/ml and 62.4 µg/ml, respectively.
System suitability
The system suitability test of the proposed method to evaluate the 
chromatographic parameters before the validation runs. The validation 
of the developed method was done as per the ICH validation guidelines.
From the linearity studies, we found that the drug obeys Beer’s and 
Lambert’s law within the sample concentration range. The percentage 
recovery of pure drug was 98–100.06%, it indicates that the developed 
method was accurate and more precise. Specificity of the method 
indicated the excipients and degradation products present in the 
formulations but it not interfering the reported method. The precision 
studies indicated that the developed method has good reproducibility. 
The system suitability parameters also reveal that the values are within 
the specified limits for the developed method. The test procedure for 
ofloxacin tablet was validated and found that the developed method is 
complies the validation parameters. The Ofloxacin sample formulation 
assay values are showed in Table 6.
CONCLUSION
An eco-friendly, rapid, and cost-effective liquid chromatographic method 
was developed for the analysis of ofloxacin in drug and pharmaceutical 
dosage form. The Hyper Persil Silica (250 x 4.6 mm, packed with 5μm) 
column was used. The carrier solution contains methanol and water 
in the ratio of 90:10 and supplied to column by isocratic mode. The 
respective linear regression equation being y = 70353x + 29.6 and 
the correlation coefficient was R² = 1. The mobile phase supplied at 
1.0 ml/min and eluted substance is analyzed at 270 nm. The retention 
time of ofloxacin was found to be 3.4 min. The linearity of the developed 
method was 5–30 µg/ml. The percentage recovery was found to be 
98–101.03%; it indicates that the developed method is accurate as well 
as the excipients present in the formulation not interfere the process. 
We are used only methanol and water as the mobile phase. The both 
solvents are environment safe so that developed method is eco-friendly. 
The percentage RSD value of precision analysis is <2%; it indicates that 
the developed method has complied reproducibility parameters. The 
system suitability parameters also reveal that the reported values are 
within the specified limits for the developed method. The developed 
reverse phase chromatographic method is an eco-friendly, sensitive, 
precise, and accurate method for the estimation of ofloxacin and 
marketed formulation.
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